GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Net Income Including Noncontrolling Interests

Hard to Treat Diseases (Hard to Treat Diseases) Net Income Including Noncontrolling Interests : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Hard to Treat Diseases's Net Income Including Noncontrolling Interests for the three months ended in . 20 was $0.00 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Hard to Treat Diseases's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Net Income Including Noncontrolling Interests Chart

Hard to Treat Diseases Annual Data
Trend
Net Income Including Noncontrolling Interests

Hard to Treat Diseases Quarterly Data
Net Income Including Noncontrolling Interests

Hard to Treat Diseases Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hard to Treat Diseases Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
PSID GBSN ETAH IMEXF OXIS ABMC ATOS MEDD BTHCF MTST DIGP ROSG IDYLF BZYR TBIOD TEAR GNWSF LEDIF ROKA GENE
Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Website
http://www.htdsmedical.com
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines